Healthcare
Vynleads, Inc.(VYND)
Live Price
Offline$0.49
+13.95% today
1Y Change
-13.98%
Window
Jun 23, 2025 โ Jun 4, 2026
- Market Cap
- $10.00M
- Revenue Growth
- 0.0%
- EPS Growth
- +31.9%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 4, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Vynleads, Inc. (VYND) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.49 and down 14.0% across the available one-year price window (Jun 23, 2025 โ Jun 4, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +31.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +31.9%, free cash flow +3.1% with operating margin 0.0% and ROIC 132.2%. Stock Foundry combines VYND price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 11, 2026, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +31.9%, while operating margin sits near 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 11, 2026 | โ | +0.0% | +0.0% | โ |
2026 Mar 23, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Nov 12, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VYND
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
VYND Max Drawdown
-49.59%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for VYND and SPY.
Company Overview
Vynleads, Inc.
Other OTC
Vynleads, Inc. provides health and wellness information to pre-diabetic individuals or type 2 diabetes sufferers primarily in the United States. It offers Lifestyle Blueprint, a digital guide that provides dietary recommendations for a very low calorie eight-week diet, as well as nutritional information. The company also sells nutritional supplements; and monthly subscriptions to proprietary newsletter that covers a range of healthy living-related topics. It sells its products online through constitutionalhealth.com, wearedwd.com, and dwdprotocol.com. Vynleads, Inc. was incorporated in 2015 and is headquartered in Rock Hill, South Carolina.
- Leadership
- Alex J. Mannine
- IPO Date
- Feb 24, 2020
- Employees
- 1
- Street Address
- 596 Herrons Ferry Road
- Mailing
- Rock Hill, SC, 29730
- Region
- Rock Hill, SC, US
- Reporting Currency
- USD
- Investor Line
- 845 745 0981
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- โ
Growth
- Revenue
- 0.0%
- EPS
- +31.9%
- Free Cash Flow
- +3.1%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 81.3%
- ROIC
- 132.2%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.13
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.